135 related articles for article (PubMed ID: 4340534)
21. The metabolism of adenosine 3',5'-cyclic phosphate. II. Some properties of adenosine-3',5'-cyclic-phosphate phosphodiesterase from the rat kidney.
Dousa T; Rychlík I
Biochim Biophys Acta; 1970 Mar; 204(1):10-7. PubMed ID: 4314465
[No Abstract] [Full Text] [Related]
22. Purification and properties of a cyclic nucleotide phosphodiesterase from bovine heart.
Goren EN; Rosen OM
Arch Biochem Biophys; 1972 Nov; 153(1):384-97. PubMed ID: 4346637
[No Abstract] [Full Text] [Related]
23. Effects of papaverine derivatives on cyclic AMP phosphodiesterase of human platelets.
Markwardt F; Hoffmann A
Biochem Pharmacol; 1970 Aug; 19(8):2519-20. PubMed ID: 4329211
[No Abstract] [Full Text] [Related]
24. Cyclic nucleotide phosphodiesterases.
Appleman MM; Thompson WJ; Russell TR
Adv Cyclic Nucleotide Res; 1973; 3():65-98. PubMed ID: 4361529
[No Abstract] [Full Text] [Related]
25. The regulatory role of phosphodiesterase in adenosine cyclic 3',5'-monophosphate mediated ACTH.
Ng SS KONG YC
Experientia; 1971; 27(11):1257-8. PubMed ID: 4332432
[No Abstract] [Full Text] [Related]
26. A role of cyclic nucleotides in brain metabolism.
Goldberg ND; O'Dea RF; Lust WD; Wei S; O'Toole AG
Adv Biochem Psychopharmacol; 1970; 3():67-87. PubMed ID: 4331466
[No Abstract] [Full Text] [Related]
27. Methylxanthine and non-xanthine phosphodiesterase inhibitors. Their effects on adenosine uptake and the low Km cyclic AMP phosphodiesterase in intact rat adipocyte.
Wong EH; Ooi SO
Biochem Pharmacol; 1985 Aug; 34(16):2891-6. PubMed ID: 2411270
[TBL] [Abstract][Full Text] [Related]
28. Human blood platelet 3': 5'-cyclic nucleotide phosphodiesterase. Isolation of low-Km and high-Km phosphodiesterase.
Hidaka H; Asano T
Biochim Biophys Acta; 1976 Apr; 429(2):485-97. PubMed ID: 177073
[TBL] [Abstract][Full Text] [Related]
29. Receptor-mediated gonadotropin action in the ovary. Regulatory role of cyclic nucleotide phosphodiesterase(s) in intracellular adenosine 3':5'-cyclic monophosphate turnover and gonadotropin-stimulated progesterone production by rat ovarian cells.
Azhar S; Menon KM
Biochem J; 1979 Apr; 180(1):201-11. PubMed ID: 226066
[TBL] [Abstract][Full Text] [Related]
30. Metabolic regulation of steroidogenesis in isolated adrenal cells of rat. Relationship of adrenocorticotropin-, adenosine 3':5'-monophosphate-and guanosine 3':5'-monophosphate-stimulated steroidogenesis with the activation of protein kinase.
Sharma RK; Ahmed NK; Shanker G
Eur J Biochem; 1976 Nov; 70(2):427-33. PubMed ID: 188647
[TBL] [Abstract][Full Text] [Related]
31. Inhibition by papaverine and eupaverin of 3', 5'-cyclic AMP phosphodiesterase from rabbit skeletal muscle.
Toson GC; Carpenedo F
Naunyn Schmiedebergs Arch Pharmacol; 1972; 273(1):168-71. PubMed ID: 4338394
[No Abstract] [Full Text] [Related]
32. Adrenal cells in tissue culture. X. On the mechanism of the stimulation of steroidogenesis by cyclic cytidine monophosphate.
Kowal J
Endocrinology; 1973 Aug; 93(2):461-8. PubMed ID: 4352445
[No Abstract] [Full Text] [Related]
33. Cyclic nucleotide phosphodiesterase in pea seedlings.
Lin PP; Varner JE
Biochim Biophys Acta; 1972 Aug; 276(2):454-74. PubMed ID: 4341591
[No Abstract] [Full Text] [Related]
34. Phosphodiesterase activity and the potentiation by theophylline of adrenocorticotrophin stimulated steroidogenesis and adenosine 3',5'-monophosphate levels in isolated rat adrenal cells.
Mackie C; Schulster D
Biochem Biophys Res Commun; 1973 Jul; 53(2):545-51. PubMed ID: 4352069
[No Abstract] [Full Text] [Related]
35. Properties of a phosphodiesterase with high affinity for adenosine 3',5'-cyclic phosphate.
Huang YC; Kemp RG
Biochemistry; 1971 Jun; 10(12):2278-83. PubMed ID: 4329874
[No Abstract] [Full Text] [Related]
36. Inhibition by papaverine of 3',5'-nucleotide-phosphodiesterase (E.C.3.1.4.1.) from bovine uterus muscle.
Rufeger U; Tellhelm B; Frimmer M
Naunyn Schmiedebergs Arch Pharmakol; 1971; 270(4):428-30. PubMed ID: 4328803
[No Abstract] [Full Text] [Related]
37. The ability of denbufylline to inhibit cyclic nucleotide phosphodiesterase and its affinity for adenosine receptors and the adenosine re-uptake site.
Nicholson CD; Jackman SA; Wilke R
Br J Pharmacol; 1989 Jul; 97(3):889-97. PubMed ID: 2474352
[TBL] [Abstract][Full Text] [Related]
38. Xanthines and skeletal muscle: lack of relationship between phosphodiesterase inhibition and increased twitch tension in rat diaphragms.
Kramer GL; Wells JN
Mol Pharmacol; 1980 Jan; 17(1):73-8. PubMed ID: 6247639
[No Abstract] [Full Text] [Related]
39. The metabolism of cyclic nucleotides in the guinea-pig pancreas. Cyclic AMP phosphodiesterase and cyclic GMP phosphodiesterase.
Methven P; Lemon M; Bhoola K
Biochem J; 1980 Feb; 186(2):491-8. PubMed ID: 6246887
[TBL] [Abstract][Full Text] [Related]
40. Selective inhibition of separated forms of human platelet cyclic nucleotide phosphodiesterase by platelet aggregation inhibitors.
Asano T; Ochiai Y; Hidaka H
Mol Pharmacol; 1977 May; 13(3):400-6. PubMed ID: 195193
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
